Navigation Links
AVANIR Pharmaceuticals Invites Investors to Conference Call Regarding FDA Approval of NUEDEXTA™ on Monday November 1, 2010
Date:11/1/2010

ALISO VIEJO, Calif., Nov. 1, 2010 /PRNewswire-FirstCall/ -- AVANIR Pharmaceuticals, Inc. (Nasdaq: AVNR) today announced a management conference call to discuss the approval of NUEDEXTA™ (dextromethorphan hydrobromide and quinidine sulfate) by the U.S. Food and Drug Administration (FDA).  The call is scheduled for today, Monday November 1, 2010 at 5:15 a.m. Pacific time / 8:15 a.m. Eastern time.  

The live call can be accessed by dialing (877) 558-3407 for domestic callers and (706) 679-1941 for international callers.  The conference ID number is 22130601.  A webcast of the live call can be accessed by visiting AVANIR's corporate website at www.avanir.com.  To view the live webcast, please go to AVANIR's website prior to the start of the call to register, download, and install the necessary software.

An archived copy of the webcast will be available on AVANIR's website for 30 days, and a telephone replay will be available through November 6, 2010, by dialing (800) 642-1687 (domestic) or (706) 645-9291 (international) and entering the conference ID number 22130601.  

About NUEDEXTA

NUEDEXTA™ is the first and only FDA-approved treatment for pseudobulbar affect (PBA).  NUEDEXTA is an innovative combination of two well-characterized components; dextromethorphan hydrobromide (20 mg), the ingredient active in the central nervous system, and quinidine sulfate (10 mg), a metabolic inhibitor enabling therapeutic dextromethorphan concentrations.  NUEDEXTA acts on sigma-1 and NMDA receptors in the brain, although the mechanism by which NUEDEXTA exerts therapeutic effects in patients with PBA is unknown.  

NUEDEXTA is indicated for the treatment of pseudobulbar affect (PBA).  PBA occurs secondary to a variety of otherwise unrelated neurologi
'/>"/>

SOURCE AVANIR Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. AVANIR Pharmaceuticals Invites Investors to Fiscal 2010 Third Quarter Conference Call
2. AVANIR Pharmaceuticals to Present at the UBS Global Life Sciences Conference
3. AVANIR Pharmaceuticals Announces FDA Approval of NUEDEXTA™
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... 2015  ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ... commercialization of targeted antiviral therapies, announced today that it ... Conference, to be held March 8-11, 2015, in ... James Sapirstein , Chief Executive Officer, will provide an ... and will be available to participate in one-on-one meetings ...
(Date:3/5/2015)... March 5, 2015 According to ... by Product (Systems and Disposables), by Type (Invasive, Minimally ... Home and Ambulatory Sites) - Analysis & Global Forecast ... is expected to reach $1,107.4 Million by 2019 from ... at a CAGR of 4.5% during the forecast period. ...
(Date:3/5/2015)... 2015 Ascendis Pharma A/S, a clinical ... technology to address significant unmet medical needs, today ... ENDO 2015 conference being held at the San ... on Thursday, March 5, 2015 during the Pediatric ... PST, and are titled: ...
Breaking Medicine Technology:ContraVir to Present at 27th Annual ROTH Conference 2Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 2Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 3Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 4Ascendis Pharma to Present at ENDO 2015 2
... Mass., Aug. 17 Block Engineering, a leading ... launch of a family of next-generation, revolutionary spectrometers ... Daniel Cavicchio, chairman of Block Engineering, commented, "This ... and it is the result of a multiyear ...
... 17 Exceptionally high costs.  Long research and development ... regulatory reviews.  Dependence on out-dated information technology options.  It,s ... much valuable information being wasted.   ... development industry have led to the formation of a ...
Cached Medicine Technology:Block Engineering Introduces Family of Quantum Cascade Laser Mid-IR Spectrometers 2RedOak Logic's Mission: Transform Pharmaceutical Industry Drug Development 2RedOak Logic's Mission: Transform Pharmaceutical Industry Drug Development 3RedOak Logic's Mission: Transform Pharmaceutical Industry Drug Development 4
(Date:3/5/2015)... Leading nutritional supplement provider Metabolic Nutrition ... and Arnold Fitness EXPO in Columbus, Ohio ... a display booth featuring free samples of its superior ... class-leading fat burner Synedrex. The company will also be ... its top-of-the-line supplements and miniature action figures of its ...
(Date:3/5/2015)... 2015 Think it’s tough to get kids ... get them to brush their teeth. That’s a finding from ... by Delta Dental(1) in conjunction with National Parenting Month in ... getting kids to brush their teeth is one of the ... slightly higher than getting children to eat vegetables regularly (42 ...
(Date:3/5/2015)... 05, 2015 The recent influx of ... promises is alarming, with more and more internet ads ... actual prescription, making it easy for more people to ... their money and endanger their health. The company urges ... prescription online diet pills: , 1.    Where are the products ...
(Date:3/5/2015)... The MTC 5-day Fundamental Implantology Course has been ... variety of dental disciplines, to offer implant placement treatment ... onset we wanted this course to be a truly ... excellence of the lecturers and the sheer energy and ... satisfied our aims." , Unlike large-scale training operations, ...
(Date:3/5/2015)... 05, 2015 Hope For The Warriors® is ... Shoot to be held at Beretta Shooting Grounds (Dover Furnace) ... proceeds from the event will benefit Hope For The Warriors®, ... restoring the family unit, and restoring hope for our service ... our nation’s heroes through a day of clay shooting at ...
Breaking Medicine News(10 mins):Health News:Metabolic Nutrition Exhibiting at 2015 Arnold Sports Festival and Fitness EXPO This Week 2Health News:Delta Dental Survey Says Parents Have Harder Time Getting Kids to Brush than to Eat Vegetables 2Health News:Delta Dental Survey Says Parents Have Harder Time Getting Kids to Brush than to Eat Vegetables 3Health News:Diet Doc Announces Four Simple Questions that Dieters Must Ask Prior to Purchasing Online Diet Pills 2Health News:Diet Doc Announces Four Simple Questions that Dieters Must Ask Prior to Purchasing Online Diet Pills 3Health News:MIS Global Training Center (MTC) Launches its Fundamental Implantology Course for Doctors - with a Difference 2Health News:Hope For The Warriors Announces New York Clay Shoot to Benefit Military Families 2
... Researchers have been able to identify neural signatures ... record, measure and analyze both behavior and ... ,Researchers used a specially designed dual-electroencephalogram (EEG) and ... in this study, The Phi Complex as a ...
... to become one of the first major universities in the ... campus. University officials intend to give the Fayetteville campus ... to the policy: the ban is scheduled to go into ... health issue, said Mary Alice Serafini, assistant vice chancellor for ...
... the Ontario Cancer Institute at Princess Margaret Hospital have successfully ... new cancer drug that is triggered by a laser ... ,In a study published today in the Proceedings of ... Scientist - Division of Biophysics and Bioimaging, Joey and Toby ...
... (Childrens Hospital Boston) and colleagues have identified the cancer ... of childhood. ,'Identifying the cancer stem ... in ERMS will likely lead to new insights into ... explains Dr. Zon. ,Rhabdomyosarcoma (RMS) is an ...
... Rsearchers at the University of Florida, found that self-confidence ... more over a lifetime. Believing in yourself ... the study found. ,People with high opinions ... salaries in middle age than their less confident counterparts, ...
... Desperate Housewives actress -Terri Hatcher, has a unique way of using ... ,The actress is following the advice of her Pharmacist ... and sour wine in a bathwater. It is well is a ... good after four to five days. ,"When you're alone ...
Cached Medicine News:Health News:New Brain Neuromarker May Shed Light on Autism and Schizophrenia 2Health News:New Brain Neuromarker May Shed Light on Autism and Schizophrenia 3Health News:University of Arkansas to Ban Tobacco from Its Campus 2Health News:University of Arkansas to Ban Tobacco from Its Campus 3Health News:Scientists Activate New Cancer Drug Using Light and Oxygen 2Health News:Pediatric Cancer Stem Cell Identified 2Health News:Teenage Self Confidence Can Translate Later into Material Wealth 2Health News:Teenage Self Confidence Can Translate Later into Material Wealth 3
7 mm strong curved blade. Round handle....
3 mm diameter roller blade, 15 mm from angle to tip. Round handle....
No. 4. 0.75 mm wide x 5 mm long, lightly curved tip, offset to the left. Hexagonal handle....
Large. 2.5 mm diameter blade. Angled up 45 degrees. Round handle....
Medicine Products: